5 Best Stocks to Buy Now According to Michael Platt’s BlueCrest Capital

In this article, we will discuss the 5 best stocks to buy now according to Michael Platt’s BlueCrest Capital. If you want to read our detailed analysis of Platt’s history, his investment strategy, and his hedge-fund performance, go directly to 10 Best Stocks to Buy Now According to Michael Platt’s BlueCrest Capital

5. Danaher Corp. (NYSE:DHR)

BlueCrest Capital Management’s Stake Value: $31.9M

Percentage of BlueCrest Capital’s 13F Portfolio: 1.03%

Number of Hedge Fund Holdings: 83

Danaher Corporation (NYSE:DHR) is a globally diversified American conglomerate company based out of Washington D.C. It designs, manufactures and markets medical, industrial, professional and commercial products and services. As of the first quarter of 2022,  Fisher Asset Management is the largest shareholder in the stock, with a total stake value of almost $1.1 billion.

Danaher Corporation (NYSE:DHR) contributes 1.03% to Platt’s 13F investment portfolio. The hedge-fund billionaire owns 108,644 shares worth about $31.9 million, raising his stake in Danaher (NYSE:DHR) by 29%.

On June 1, RBC Capital analyst Deane Dray elevated Danaher Corporation’s (NYSE:DHR) rating to ‘Outperform’, raising the price target to $310 from $299. He observed that the “high quality, defensive portfolio looks incrementally more attractive given the higher Wall of Worry/macro fear”

Cooper Investors Global Equities Fund mentioned Danaher Corporation (NASDAQ:DHR) in their Q1 2022 investor letter. This is what they had to say:

“This combination of attributes was not in favor during a quarter where the market rotated into larger, more traditional index heavyweights that, while growing more slowly and generating lower returns on capital, typically trade on lower headline multiples. In Healthcare for example, we saw portfolio holdings Danaher (NASDAQ:DHR) fall 10-15% in the quarter. Given the relative business quality and growth prospects for a life sciences capital allocator champion like Danaher (NASDAQ:DHR) versus a large diversified pharma company, we think this period of underperformance is likely more a blip than a trend.”

4. NextEra Energy Inc. (NYSE:NEE)

BlueCrest Capital Management’s Stake Value: $35.5M

Percentage of BlueCrest Capital’s 13F Portfolio: 1.15%

Number of Hedge Fund Holdings: 64

Based in Juno Beach, Florida, NextEra Energy Inc. (NYSE:NEE) is an American energy company. It is the largest electric utility holding company in the world by market capitalization and ranked 167th on the 2018 Fortune 500 of the largest US corporations by revenue. As of Q1 2022, Ken Fisher’s Fisher Asset Management is the leading shareholder, owning over 15 million shares worth around $1.3 billion.

Platt’s BlueCrest Capital has strengthened its hold over NextEra Energy Inc. (NYSE:NEE) by a staggering 1025% this quarter, with a stake value of $35.5 million. This means that NextEra Energy Inc. (NYSE:NEE) makes up for 1.15% of BlueCrest Capital’s 13F investment portfolio.

3. Clarivate Plc (NYSE:CLVT)

BlueCrest Capital Management’s Stake Value: $35.7M

Percentage of BlueCrest Capital’s 13F Portfolio: 1.16%

Number of Hedge Fund Holdings: 36

Based in Philadelphia and London, Clarivate Plc (NYSE:CLVT) is an American publicly traded analytics company which runs multiple subscription-based services, in the areas of bibliometrics, scientometrics, market intelligence and much more. Formed in 2016, Clarivate Plc (NYSE:CLVT) has made a reputation for itself within the scientific community as one of the only companies to calculate the ‘impact factor’. Hedge fund sentiment around the stock has decreased this quarter, with 36 hedge funds investing in the stock, down from the preceding quarter where the number of long hedge fund positions was 42.

Here is what Baron Asset Fund has to say about Clarivate Plc (NYSE:CLVT) in its Q1 2022 investor letter:

“We reduced our stake in Clarivate Plc (NYSE:CLVT), an information services company focused on the scientific and academic markets, after the company reported particularly disappointing fourth quarter earnings results.”

2. GFL Environmental Inc. (NYSE:GFL)

BlueCrest Capital Management’s Stake Value: $39.4M

Percentage of BlueCrest Capital’s 13F Portfolio:1.28 %

Number of Hedge Fund Holdings: 27

GFL Environmental (NYSE:GFL) is a waste management company based out of Toronto, Canada. It provides environmental services to municipal, residential, commercial, institutional and industrial clients. As of the first quarter of 2022, Robert Pohly’s Samlyn Capital is the leading shareholder in GFL Environmental (NYSE:GFL), with a consolidated stake value of over $135 million.

BlueCrest Capital owns 531,834 shares in GFL Environmental (NYSE:GFL), with a stake value of $39.4 million. A result of Platt increasing his hold over the stock by 192%, the company now contributes 1.28% to BlueCrest’s Q1 2022 investment portfolio.

1. Criteo S.A. (NASDAQ:CRTO)

BlueCrest Capital Management’s Stake Value: $61.6M

Percentage of BlueCrest Capital’s 13F Portfolio: 2%

Number of Hedge Fund Holdings: 17

Based in Paris, France, Criteo (NASDAQ:CRTO) is a publicly traded advertising company that provides online display advertisements, generated based on the online browsing preferences and behavior for each specific customer. The company operates on the cost-per-click model. Owning more than 2.2 billion shares, Platt’s BlueCrest Capital is the largest shareholder in the stock, with a total stake value of $61.6 million. Platt has maintained his hold over the stock, neither increasing nor decreasing it compared to the preceding quarter, with Criteo (NASDAQ:CRTO) contributing 2% to BlueCrest’s 13F investment portfolio.

Investor interest in Criteo (NASDAQ:CRTO) has slightly decreased in the first quarter, with only 17 hedge funds listing Criteo (NASDAQ:CRTO) in their portfolios, down from 18 in the previous quarter.